Sinagra, E., Tomasello, G., Cappello, F., Leone, A., Cottone, M., Bellavia, M., Rossi, F., Facella, T., Damiani, P., Zeenny, M.N., Damiani, F., Abruzzo, A., Damiano, G., Palumbo, V.D., Cocchi, M., Jurjus, A., Spinelli, G., Lo Monte, A.I. and Raimondo, D. (2013) Probiotics, Prebiotics and Symbiotics in Inflammatory Bowel Diseases: State-of-the-Art and New Insights. Journal of Biological Regulators & Homeostatic Agents, 27, 919-933.

has been cited by the following article:

• TITLE: Inflammatory Bowel Diseases: What Do We Still Need to Investigate?

  AUTHORS: Marina Taus, Debora Busni, Daniele Fumelli, Arianna Paci, Giulia Nicolai, Albano Nicolai

  KEYWORDS: Inflammatory Bowel Desease, Fecal Mass Transplantation, Nutrition and Macrobiota

  JOURNAL NAME: Open Journal of Gastroenterology, Vol.5 No.10, October 28, 2015

  ABSTRACT: Inflammatory bowel disease (IBD) including Crohn (CD) and ulcerative colitis (UC), is intestinal disorders with an unknown specific etiology. Many factors are involved in the pathogenesis: genetic, environment, nutrition, immunity and intestinal dysbiosis. In the present work, we review the most important trigger mechanisms involved in IBD, with a particular regard to the role of microbiota and fecal mass transplantation as a new therapeutic approach, that even if it can be considered safe and effective, data are necessary regarding all procedures not yet standardized and timing of treatment.